| INCI Nomenclature: | Tranexamic acid |
| Use Level: | 2-5% |
| Biological Activity: | Skin depigmentation via plasmin inhibition Anti-inflammation Hemostatic |
Derivative of the amino acid lysine is a next-generation dark spot corrector whose mode of action impacts plasmin activity associated with melanogenesis. Significantly increases the luminosity of dark spots leading to lighter, less pigmented spots. Creates a more even, homogeneous and uniform skin tone. Enhances skin radiance and brightness.